Determining threshold values for success after surgical treatment of lumbar spondylodiscitis using quality of life scores.

Authors:
Yagdiran A; Sircar K; Jung N; Eysel P; Bredow J and 1 more

Journal:
Acta Orthop Traumatol Turc

Publication Year: 2023

DOI:
10.5152/j.aott.2023.22137

PMCID:
PMC10543916

PMID:
37395356

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Orthop Traumatol Turc

Abbreviation: Acta Orthop Traumatol Turc

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Traumatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acute bilateral extensor pollicis longus tendon rupture following bilateral displaced distal radius…
Kızılay YO; Turan K. (2023) - Transparency Score: 3/6
Adrenomedullin has no effect on segmental bone defect healing but increases bone mineral density in…
Kaymakoglu M; Ciftci E; Korkusuz P and 3 more (2023) - Transparency Score: 3/6
Analysis of predictive factors for post-traumatic osteoarthritis and poor outcomes in acetabular fr…
Kavak M; Çeliksöz AH; Tokmak B and 1 more (2023) - Transparency Score: 3/6
Analysis of the factors affecting school attendance in pediatric fractures.
Zhamilov V; Bozoglan M; Reisoglu A and 3 more (2023) - Transparency Score: 3/6
A new scoring system for predicting cut-out risk in patients with intertrochanteric femur fractures…
Kulakoglu B; Ozdemir G; Bingol O and 3 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Interests: Each author certifies that there are no funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article related to the author or any immediate family members except for NJ. NJ has received lecture fees from Gilead, Infectopharm, MSD, Bayer; Medacta and Labor Stein and travel grants from Pfizer, Gilead, Basilea, Correvio, Pfizer and Novartis and grants from an observational study from Infectopharm."

Evidence found in paper:

"Funding: We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 491454339)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025